Fundraising FoxARCH Venture Partners — 2016 Investments
4 investments dated 2016 · listed companies and verified rows first · show all
Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
David Walt(Director)inErnest Orticerio(Executive Officer)Ernest Oriticerio(Executive Officer)Masoud Toloue(Former Chief Executive Officer)in
BoardJohn Connolly(Director)in
Board seatKeith Crandell· per SEC Form D
Co-investorsBain Capital VenturesFoothill VenturesIn-Q-TelKhosla VenturesNovalis LifeSciences
Agrivida develops enzyme technology for animal feed and nutrition, improving efficiency in poultry, swine, and other livestock production.
AgTechBiotechFoodTechMassachusetts, US
R. Michael Raab(Executive Officer)Daniel Meagher(Executive Officer, Director)Jeremy Schley Johnson(Executive Officer)
BoardRob Johnson(Director)Mark Austin(Director)Robert Bucklin(Director)
Board seatClinton Bybee· per SEC Form D
Co-investorsMiddleland CapitalPresidio VenturesCultivian Sandbox VenturesDag VenturesKleiner Perkins
Unity Biotechnology was a biotechnology company that is no longer operating.
BiotechBrisbane, US
Nathaniel E. David(Executive Officer, Director)inDan Marquess(Executive Officer)inKeith Leonard(Executive Officer, Director)inTamara Tompkins(Executive Officer)inBob Goeltz(Executive Officer)inJamie Dananberg(Executive Officer)in
Board seatRobert NelsenKristina Burow· per SEC Form D
Co-investorsage1Alumni VenturesCycad Group LLCEcoR1 CapitalKhosla VenturesVenrock+6 more
LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.
AI & Machine LearningBiotechDeep TechCambridge, US
Gregory L. Verdine(Executive Officer, Director)Gregory Verdine, Ph.D.
BoardHingge Hsu(Executive Officer, Director)Weiqing Zhou(Executive Officer, Director)
Co-investorsGV (Google Ventures)RA CapitalAisling CapitalAlexandriaBezos ExpeditionsBlue Pool Capital+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.